- Category: News
- Published on 16 July 2013
- Written by Mount Vernon Optic-Herald
East Texas cardiologists are the first in Texas to implant an investigational bioresorbable vascular scaffold - similar to a stent except it eventually dissolves - for patients with heart disease as part of a national clinical trial.
Absorb, manufactured by the healthcare company Abbott, is a small mesh tube that is designed to open a blocked heart vessel and restore blood flow to the heart. Unlike a metallic stent that remains permanently in the body, Absorb is referred to as a scaffold to indicate that it is a temporary structure. For more details about the new implant see the July 11 edition of the Mount Vernon Optic-Herald.